학술논문

Pharmacokinetic Properties of an FDA-approved Intranasal Nalmefene Formulation for the Treatment of Opioid Overdose
Document Type
Article
Source
In: Clinical Pharmacology in Drug Development. (Clinical Pharmacology in Drug Development, January 2024, 13(1):58-69)
Subject
Language
English
ISSN
21607648
2160763X